Article Information
History
- July 11, 2020.
Article Versions
- You are currently viewing Version 1 of this article (July 11, 2020 - 20:54).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Qing Lei1,+,
- Yang Li2,+,
- Hongyan Hou3,+,
- Feng Wang3,
- Yandi Zhang1,
- Danyun Lai2,
- Banga Ndzouboukou Jo-Lewis1,
- Zhaowei Xu2,
- Bo Zhang3,
- Hong Chen2,
- Zhuqing Ouyang1,
- Junbiao Xue2,
- Xiaosong Lin1,
- Yunxiao Zheng2,
- Zhongjie Yao1,
- Xuening Wang2,
- Caizheng Yu4,
- Hewei Jiang2,
- Hainan Zhang2,
- Huan Qi2,
- Shujuan Guo2,
- Shenghai Huang5,
- Ziyong Sun3,*,
- Shengce Tao2,* and
- Xionglin Fan1,*,#
- 1Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China
- 3Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 4Department of Public Health, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 5Department of Microbiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, PR China
- ↵#Corresponding author; email: xlfan{at}hust.edu.cn
↵+ These authors contributed equally to this paper.
Posted July 11, 2020.
Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
15
Blogs/Media
Author Videos